Class IITerminated in FDA datasetOct 7, 2024

Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle.

Recalling firm: Nestle Product Technology Center - Nestle Health Science

Why it was recalled

Nestle Health Science (NHS U.S., LLC) is initiating a recall of Douglas Labs Stress-B-Plus Dietary Supplement Tablets, 90 tablets per bottle. The bottle is white and made of plastic. Lot Numbers 50335944,50344396, expiration date 04/11/2026. The product is being recalled because of Incorrect formulation manufactured vs label claims. Product was manufactured with Niacin (as Nicotinic acid) and supplement facts panel states contains Niacin (as Niacinamide).

Check the codes ↓

The exact product

Douglas Labs Stress-B-Plus Dietary Supplement, Tablets, 90 tablets per bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026

Check the codes

Compare these FDA-provided codes, lot numbers or dates with the product you have.

Match the product, size and code together. A similar name alone does not identify your batch.

Original FDA code information

Lot Codes: 50335944, 50344396

TypeCode / valueContext
expiration04/11/2026bottle. UPC # 10539 97452, Lot Numbers ,50335944 and 50344396. Expiration Date 04/11/2026
lot50335944Lot Codes: 50335944, 50344396
lot50344396Lot Codes: 50335944, 50344396

Recall details

Recall number
F-0139-2025
Event ID
95519
FDA status
Terminated
Initiated
Oct 7, 2024
Reported
Nov 27, 2024
Classified
Nov 17, 2024
Terminated
Jun 24, 2026
Quantity
3,269 bottles in market
Location
Bridgewater, NJ, United States
Initiation type
Voluntary: Firm initiated
Notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Where it was distributed

AK,AZ,CA,CO,DE,FL,GA,IA,ID,IL,IN,KS,KY,LA,MA,MD,MI,MN,MO,NC,NH,NJ,NM,NY,OH,OK,OR,PA,SD,TN,TX,VA,WA,WI,WV

FDA source record · F-0139-2025

Data updated September 16, 2026. View official FDA data ↗

A missing code match is not a guarantee of safety. Follow official FDA and manufacturer guidance.